Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that three abstracts ...
Partners With Mount Sinai To Accelerate AI-ECG Development And Validation. The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...
An artificial intelligence (AI)-based method for interpreting ECGs performed better than standard approaches in detecting ...
Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced ...
Clinicians rely daily on electrocardiograms (ECG) to detect common cardiovascular conditions, but accurate diagnoses require high levels of expertise. In a new study that reviewed nearly 1 million ...
San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...
Please provide your email address to receive an email when new articles are posted on . AliveCor announced its next-generation AI algorithms for ECG interpretation have received 510(k) clearance from ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results